GO terms in STK16


Term TypeEvidence TypeGO Term IDGO Des.
MFIEAGO:0001077transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding
MFIEAGO:0004715non-membrane spanning protein tyrosine kinase activity
MFIPIGO:0005515protein binding
MFIEAGO:0005524ATP binding
CCIEAGO:0005798Golgi-associated vesicle
CCIDAGO:0005829cytosol
CCIEAGO:0016020membrane
CCIEAGO:0048471perinuclear region of cytoplasm
BPIEAGO:0006366transcription by RNA polymerase II
BPIEAGO:0018108peptidyl-tyrosine phosphorylation
BPIEAGO:0045944positive regulation of transcription by RNA polymerase II
BPIDAGO:0046777protein autophosphorylation
BPIBAGO:0071560cellular response to transforming growth factor beta stimulus

Gene expression in normal tissue: STK16

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in STK16


DatabasePathway IDPathway Des.

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD137Indisulam3
iGMDRD289Parthenolide3
iGMDRD870BRD636101
iGMDRD872BRD71373
iGMDRD188Piperlongumine3
iGMDRD398Sepantronium3
iGMDRD147Prima-13
iGMDRD690PRIMA-1MET3
iGMDRD268Cerulenin3
iGMDRD126Tipifarnib3
iGMDRD772BRD47703
iGMDRD512nutlin 33
iGMDRD144NSC953973
iGMDRD150RITA3
iGMDRD781Sirolimus3
iGMDRD394BX-7951
iGMDRD634SCHEMBL26080411

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in STK16

​​​​